TRAP™ Discovered Pipeline of Small Molecular Product Candidates
	Therapeutic Area	Target			Status
	Cancer	TLK58747			Pre-IND Studies
		Dual Aurora-VEGFR kinase			IND Candidate Selection
		VEGFR2			In vivo Proof of Concept Achieved
		PLK-1			In vivo Proof of Concept Achieved
		Proteasome			In vivo Proof of Concept Achieved
		DNA-MT			Inhibitors Discovered
		PI3K			Inhibitors Discovered
		TrkA			Inhibitors Discovered
	Multiple Sclerosis	GPCR			Out-licensed
	Metabolic Diseases	IRK			Out-licensed

For further licensing information, please contact:

Marc L. Steuer
Senior Vice President, Business Development
Telik, Inc.
3165 Porter Drive
Palo Alto, CA 94304
Tel: +1 (650) 845-7700
Fax: +1 (650) 845-7800
E-Mail: BusinessDev@telik.com

Home | About Telik | Pipeline | Clinical Trials | Investor Info | Careers | Contact | Sitemap | Legal Notice

3165 Porter Drive, Palo Alto, CA 94304Tel 650-845-7700Fax 650-845-7800
©2008 Telik, Inc. All rights reserved.